Please use this identifier to cite or link to this item:
|Title:||Low 25-hydroxyvitamin D levels are associated with vitiligo: a systematic review and meta-analysis|
Columbia University, College of Physicians and Surgeons
|Keywords:||Immunology and Microbiology|
|Citation:||Photodermatology Photoimmunology and Photomedicine. Vol.32, No.4 (2016), 181-190|
|Abstract:||© 2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd Background: Vitamin D deficiency is associated with a number of autoimmune diseases. We completed a meta-analysis of observational studies to establish whether there was a relationship between hypovitaminosis D and the autoimmune skin disease vitiligo. Methods: Comprehensive search was applied in the MEDLINE and EMBASE databases from their inception to December 2015. Inclusion criteria were observational studies that assessed 25-hydroxyvitamin D (25(OH)D) levels in adults with vitiligo. The main outcome was the mean difference in serum 25(OH)D level between patients with vitiligo and controls. Results: Our search strategy identified 383 articles; seventeen studies met the criteria for full-length review and seven studies, containing the data of 1200 patients, were included in a random-effects model meta-analysis. The pooled mean difference in serum 25-hydroxyvitamin D concentration between patients with vitiligo and controls was −7.45 ng/ml (95% confidence interval, −12.99 to −1.91, P-value = 0.01). The between-study heterogeneity (I2) was 96%, P = value<0.001. Conclusions: This meta-analysis identifies a significant relationship between low 25-hydroxyvitamin D levels and vitiligo, but does not prove causation. Our findings emphasize the importance of measuring 25-hydroxyvitamin D levels in patients with vitiligo. Further studies will be needed to establish whether vitamin D supplementation in this population improves the outcome of vitiligo.|
|Appears in Collections:||Scopus 2016-2017|
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.